SCHEMBL4903840

SCHEMBL4903840

CCN(c1nc2cc(C)ccc2o1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
ALDH1A1 P00352 2/20 0.47
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
C1R P00736 2/20 0.43
PRSS1 P07477 2/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 3/20 0.39
CASP3 P42574 3/20 0.39
RAB9A P51151 3/20 0.39
SENP7 Q9BQF6 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 3/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895797 0.91 HPGD (0.46) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4898294 0.90 C1R (0.49) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4904431 0.89 C1R (0.45) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4906365 0.89 ALDH1A1 (0.42) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4905727 0.89 HPGD (0.47) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4903620 0.89 C1R (0.42) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4899819 0.89 C1R (0.51) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4894363 0.88 PRSS1 (0.40) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4899763 0.82 ALDH1A1 (0.41) HPGDALDH1A1HSD17B10ALOX15C1R
SCHEMBL4902845 0.81 NPC1 (0.38) HPGDALDH1A1HSD17B10C1RPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HPGD 724/4885ALDH1A1 2956/4885HSD17B10 434/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HPGD 724/4885ALDH1A1 2956/4885HSD17B10 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.